Although our proteomics study revealed MET phosphorylation and activation of the downstream signaling pathways in the resected tumor sample, this activation cannot be directly attributed to the R970C mutation as it was not confirmed in the resected tumor specimen. This evidence concerns the gene MET and neoplasm.